ÂÜÀòÂÒÂ×

Pepper Landson has been a driving force in novel therapeutics for critical healthcare needs for three decades. Her efforts have impacted programs in Neurology (Rebif®), Oncology (Provenge®), Nephrology, and Infectious Disease. She has a proven record of creating value in early stage companies. Combining her skills in business development and operations with an extensive drug development background, she is championing disease modifying treatments for the critical diseases of aging. She has worked exclusively on the Amadorin technology for neurodegenerative diseases and serious diabetic complications for the last decade. Pepper has raised dilutive and non-dilutive funding and supported a successful IPO.